To include your compound in the COVID-19 Resource Center, submit it here.

FDA to utilize EU manufacturing inspections

As part of a mutual recognition agreement between FDA, EMA and the European Commission to avoid duplicate drug manufacturing facility inspections and reduce costs,

Read the full 243 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE